Biosciences
Our researchers in have a rich legacy of collaboration with government agencies and industry partners that improve health outcomes and well-being around the world. SRI Biosciences projects range from high-impact, early-stage research to drug co-development with pharmaceutical and biotech companies.
-
SRI identifies predictors of adolescent obesity
As part of a nationwide longitudinal study of adolescent brain development, researchers use AI to analyze data to pinpoint obesity risk factors.
-
Kristien Mortelmans: Decades of contributions to SRI and the fields of industrial, medical, and environmental microbiology
SRI’s Senior Microbiologist Emeritus receives the prestigious Society for Industrial Microbiology and Biotechnology fellowship award for exceptional dedication.
-
Tips for back-to-school success
Three experts offer actionable strategies to navigate social media, sleep, and helping prepare children for new routines.
-
Tyson McDonald: How radiation impacts human biology in space and on Earth
A switch from studying medical physics to radiation biology charted the course for fascinating research.
-
SRI’s Genome Explorer: Enhanced genome browser delivers better user experience
Navigating genomes just became easier with dynamically responsive zoom and high-density display.
-
A new malaria treatment aims to provide protection from the disease
The injectable formulation is affordable and easily administered.
-
SRI sleep expert Fiona Baker discusses menopausal insomnia
Researchers study how menopause can affect sleep and women’s physical and mental health.
-
SRI researchers use AI to study deadly viruses
Machine learning algorithms identify how hemorrhagic fever viruses hijack human cells.
-
SRI earns FDA Orphan Drug Designation for pancreatic cancer
The designation accelerates clinical development of SRI’s TALL® immunotherapy and brings more affordable therapies to market faster.
-
SRI works with N4 Pharma to target and treat cells in the human body that had been unreachable
Paving the way for targeted treatments, the collaboration aims to help realize the full potential of precision healthcare.
-
Carol Green: Helping new drugs make the leap from possible to practical
Leading the effort to make sure effective therapies progress to human trials.
-
Gita Shankar: Formulating drugs for success
SRI’s director of pharmaceutical sciences works to bring new drugs safely to market while serving as a role model for women in STEM.